LAS VEGAS–(BUSINESS WIRE)–2020EHR, the leading electronic health record (EHR) and practice management solutions provider for ophthalmologists, announced today the availability of Medflow 2.0 EHR, the most advanced cloud-based EHR system. Medflow 2.0 …
Humira plus methotrexate may help manage uveitis in patients with JIA
SAN FRANCISCO – Patients with uveitis related to juvenile idiopathic arthritis may benefit from therapy with Humira and background methotrexate, according to a recently presented study. Athimalaipet V. Ramanan, FRCPCH, FRCP, and colleagues studied a group of 90 patients aged between 2 years and 18 years with uveitis associated with juvenile idiopathic arthritis (JIA). During the presentation, Ramanan said in his presentation that the mean age of patients was 9 years, about two-thirds had oligoarticular arthritis and most had active disease for about 5 years.
Family Physicians Say They Would Use Telehealth If Appropriately Paid
WASHINGTON & INDIANAPOLIS–(BUSINESS WIRE)–Nearly nine out of 10 family physicians say they would use telehealth to assist in treating their patients if they were compensated for it
Rapper, Internist ZDoggMD on the ‘Hard Doc’s Life’
Zubin Damania, an internist and rapper/singer who performs musical parodies under the name ZDoggMD, talks with Eric Topol about his love for Weird Al and his novel medical practice, Turntable Health. Medscape
A Mentor to the Ophthalmology Profession
After his receipt of the Dohlman Award, Medscape spoke with Dr Roger Steinert about his own career in ophthalmology and the significance of receiving this award for teaching excellence. Medscape Ophthalmology
Iluvien shows similar reduction in DR progression as anti-VEGF treatment
LAS VEGAS — Fluocinolone acetonide and anti-VEGF treatment similarly reduce progression of proliferative diabetic retinopathy, according to a presentation here.“The duration of continuous steroid exposure during the FAME trials provides a unique opportunity to address the clinical question of the impact of corticosteroids on progression of proliferative diabetic retinopathy (PDR),” Charles C. Wykoff, MD, PhD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology annual meeting.